Dry Eye Syndromes
Conditions
Keywords
Dry eye, Diseases of the eye and adnexa
Brief summary
Clinical trial for prevention, randomized controlled, parallel, double-blind, with three arms, which purpose is verify the nursing interventions (artificial tear gel and liquid artificial tears)effects to prevent dry eye in adult patients admitted in ICU.
Detailed description
Critically ill patients are at higher risk for dry eye and the mechanisms responsible for ocular lubrication and protection can be compromised. However, the literature diverges on which is the best clinical practice for treatment. Thus, the general objective of this study was to evaluate the risk for developing dry eye in critically ill patients and the effectiveness of three types of interventions: eye gel and eyedrops (control group). The specific objectives were: verify the most effective intervention for the prevention of dry eye from the available literature and provided by: eye gel compared to the control group eyedrops who received eye care through randomized controlled clinical trial. Patients and methods: This study is a randomized controlled trial to determine the best care for the prevention of dry eye from those available on the market (eye drops and eye gel), in the period from 14/01/2016 to 31/12/2019 . The expected result is: negative values in Schirmer test and no corneal ulcers presence.
Interventions
DEVICELACRIBELL®
Hypromellose and dextran based eyedrop, used in the treatment of dry eye.
DEVICEVIDISIC® GEL
Carbomer based gel, used in the treatment of dry eye.
Sponsors
State University of Montes Claros
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Diego Dias de Araújo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes
Inclusion criteria
* Be over 18 years; * Did not present dry eye at the time of admission; * Stay in the ICU for at least 24 hours; * Be in mechanical ventilation therapy; * Glance less than 5 per minute; * Comatose, sedated or Glasgow less than or equal to 7; * Consent to participate in research or have.
Exclusion criteria
* Have not the responsabille authorization; * Patients with severe eye disease or with history of adverse effects after use of any of the interventions proposed and not tolerate the treatment: artificial tear gel, artificial tear liquid and saline 0.9%.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Dry Eye | Five consecutive days | Interventions will be applied in both eyes of the patients from 12 to 12 hours for five consecutive days. Schirmer test will be applyed to evaluate the lacrimal volume. Fluorescein test will be applyed to evaluate the ocular surface. |
Countries
Brazil
Contacts
Primary ContactDiego D Araújo, PhD student
Backup ContactTânia CM Chianca, PhD
Outcome results
None listed